Patent ID: 9206129
Filing Date: 2015-12-08
Classification: A61K,A61P,C07D

Abstract:
1. A method of treating a glaucoma or retinitis pigmentosa comprising administering to a subject in need thereof a therapeutically effective amount of a compound of formula (I) wherein Ra is selected from the group consisting of halo, hydroxy, alkyl, halo-substituted alkyl, aryl, halo- or alkyl-substituted aryl, alkoxy, hydroxy- or carboxy-substituted alkoxy, aryloxy, halo- or alkyl-substituted aryloxy, CHO, C(O)-alkyl, C(O)-aryl, C(O)-alkyl-carboxyl, C(O)-alkylene-carboxy ester and cyano, and m is an integer selected from 0 to 4, or formate ester, acetate ester, propionate ester, butyrate ester, acrylate ester, ethylsuccinate ester, or a pharmaceutically acceptable salt thereof.